{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:50:27Z","timestamp":1793328627565,"version":"4.5.0"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.micpath.2025.107605","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:25:43Z","timestamp":1744871143000},"page":"107605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Acinetobacter baumannii: A comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies"],"prefix":"10.1016","volume":"204","author":[{"given":"Rhythm","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8877-1640","authenticated-orcid":false,"given":"Dinesh","family":"Lakhanpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.51585\/gjm.2021.3.0009","article-title":"A rapid method for the detection of motility in Acinetobacter baumannii and its association to the existence of the virulence-associated genes pilA and algW","volume":"1","author":"Wareth","year":"2021","journal-title":"Ger. J. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib3","unstructured":"The Diversity of the Genus Acinetobacter.\u201d Accessed: Nov. 18, 2024. [Online]. Available: https:\/\/www.caister.com\/hsp\/abstracts\/acineto\/01.html."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/jb.96.1.39-42.1968","article-title":"Isolation of acinetobacter from soil and water","volume":"96","author":"Baumann","year":"1968","journal-title":"J. Bacteriol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0769-2609(87)90042-1","article-title":"Identification and biotyping of clinical isolates of Acinetobacter","volume":"138","author":"Bouvet","year":"1987","journal-title":"Ann. Inst. Pasteur. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib6","doi-asserted-by":"crossref","first-page":"1110125","DOI":"10.3389\/fitd.2023.1110125","article-title":"Multidrug-resistant Acinetobacter baumannii in healthcare settings in Africa","volume":"4","author":"Agyepong","year":"2023","journal-title":"Front. Trop. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib7","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/jam.15130","article-title":"Carbapenem resistance in Acinetobacter baumannii , and their importance in hospital\u2010acquired infections: a scientific review","volume":"131","author":"Nguyen","year":"2021","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1080\/22221751.2019.1698273","article-title":"The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis","volume":"8","author":"Ayobami","year":"2019","journal-title":"Emerg. Microb. Infect."},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/14787210.2015.1025055","article-title":"Community-acquired Acinetobacter baumannii : clinical characteristics, epidemiology and pathogenesis","volume":"13","author":"Dexter","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.rppneu.2011.07.006","article-title":"Acinetobacter community-acquired pneumonia in a healthy child","volume":"18","author":"Moreira Silva","year":"2012","journal-title":"Rev. Port. Pneumol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1892\/0891-6640(2000)014<0177:TROBAA>2.3.CO;2","article-title":"The role of acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit","volume":"14","author":"Francey","year":"2000","journal-title":"J. Vet. Intern. Med."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","article-title":"Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options","volume":"39","author":"Kempf","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2025.107605_bib13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities","volume":"11","author":"Asif","year":"2018","journal-title":"Infect. Drug Resist."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nrmicro1789","article-title":"An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii","volume":"5","author":"Dijkshoorn","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-777X.68538","article-title":"Multidrug resistant acinetobacter","volume":"2","author":"Manchanda","year":"2010","journal-title":"J. Global Infect. Dis."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00924-21","article-title":"Extensively drug-resistant acinetobacter baumannii nosocomial pneumonia successfully treated with a novel antibiotic combination","volume":"65","author":"Zaidan","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib17","first-page":"24","article-title":"Pan drug-resistant Acinetobacter baumannii causing nosocomial infections among burnt children","volume":"34","author":"Sobouti","year":"2020","journal-title":"Med. J. Islam. Repub. Iran"},{"issue":"7365","key":"10.1016\/j.micpath.2025.107605_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10388","article-title":"Antibiotic resistance is ancient","volume":"477","author":"D'Costa","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1381612811306020223","article-title":"The rise of carbapenem-resistant acinetobacter baumannii","volume":"19","author":"Evans","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/antibiotics12030516","article-title":"Colistin resistance in acinetobacter baumannii: molecular mechanisms and epidemiology","volume":"12","author":"Novovi\u0107","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107605_bib22","series-title":"WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance","year":"2024"},{"key":"10.1016\/j.micpath.2025.107605_bib23","series-title":"Laboratory Manual for the ECDC Genomic-Based Survey of Carbapenem-Resistant Acinetobacter Baumannii: Version 1.2. LU","year":"2024"},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajic.2023.12.005","article-title":"An outbreak analysis of wound infection due to Acinetobacter baumannii in earthquake-trauma patients","volume":"52","author":"Eryilmaz-Eren","year":"2024","journal-title":"Am. J. Infect. Control"},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib25","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/JCM.41.8.3542-3547.2003","article-title":"Outbreak of extended-spectrum \u03b2-lactamase VEB-1-producing isolates of acinetobacter baumannii in a French hospital","volume":"41","author":"Poirel","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234684","article-title":"High mortality in an outbreak of multidrug resistant Acinetobacter baumannii infection introduced to an oncological hospital by a patient transferred from a general hospital","volume":"15","author":"Cornejo-Ju\u00e1rez","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-0711-9-17","article-title":"Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar","volume":"9","author":"Andriamanantena","year":"2010","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.micpath.2025.107605_bib28","series-title":"AMR Surveillance Network","year":"2022"},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib29","first-page":"663","article-title":"Enzyme patterns and factors associated with mortality among patients with carbapenem resistant AcinetobacterBaumannii (CRAB) bacteremia: real world evidence from a tertiary center in India","volume":"27","author":"Prayag","year":"2023","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"10.1016\/j.micpath.2025.107605_bib30","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.2147\/IDR.S428837","article-title":"Potential causes of spread of antimicrobial resistance and preventive measures in one health perspective-A review","volume":"16","author":"Endale","year":"2023","journal-title":"Infect. Drug Resist."},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib31","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3390\/microorganisms11082115","article-title":"International clones of high risk of acinetobacter baumannii\u2014definitions, history, properties and perspectives","volume":"11","author":"Shelenkov","year":"2023","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11081045","article-title":"Genomic analysis of acinetobacter baumannii isolates carrying OXA-23 and OXA-58 genes from animals reveals ST1 and ST25 as major clonal lineages","volume":"11","author":"Jacobmeyer","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107605_bib33","doi-asserted-by":"crossref","first-page":"633817","DOI":"10.3389\/fcimb.2021.633817","article-title":"Molecular epidemiology and clone transmission of carbapenem-resistant acinetobacter baumannii in ICU rooms","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib34","first-page":"1","article-title":"The first outbreak caused by acinetobacter baumannii ST208 and ST195 in China","volume":"2016","author":"Qu","year":"2016","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12864-021-07842-5","article-title":"Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics","volume":"22","author":"Bian","year":"2021","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3201\/eid1601.090852","article-title":"Worldwide dissemination of the blaOXA-23 carbapenemase gene of acinetobacter baumannii1","volume":"16","author":"Mugnier","year":"2010","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.14918","article-title":"Mobile genetic elements in Acinetobacter antibiotic\u2010resistance acquisition and dissemination","volume":"1518","author":"Noel","year":"2022","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.107605_bib38","doi-asserted-by":"crossref","first-page":"105404","DOI":"10.1016\/j.meegid.2023.105404","article-title":"Clonal evolution and antimicrobial resistance of Acinetobacter baumannii isolates from Korean hospitals over the last decade","volume":"108","author":"Jun","year":"2023","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2025.107605_bib39","doi-asserted-by":"crossref","first-page":"100847","DOI":"10.1016\/j.nmni.2021.100847","article-title":"Clonal diversity of Acinetobacter baumannii clinical isolates in Myanmar: identification of novel ST1407 harbouring blaNDM-1","volume":"40","author":"Aung","year":"2021","journal-title":"New Microbes New Infect"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13104-024-06890-w","article-title":"The context of blaOXA\u221223 gene in Iraqi carbapenem-resistant Acinetobacter baumannii isolates belonging to global clone 1 and global clone 2","volume":"17","author":"Wajid Odhafa","year":"2024","journal-title":"BMC Res. Notes"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12866-019-1401-2","article-title":"Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon","volume":"19","author":"Nawfal Dagher","year":"2019","journal-title":"BMC Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib42","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/antibiotics12071198","article-title":"Prevalence of carbapenemases in carbapenem-resistant acinetobacter baumannii isolates from the kingdom of Bahrain","volume":"12","author":"Al-Rashed","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib43","first-page":"77","article-title":"Multidrug-resistant acinetobacter baumannii infections in the United Kingdom versus Egypt: trends and potential natural products solutions","volume":"12","author":"Elwakil","year":"2023","journal-title":"Antibiot. Basel Switz."},{"key":"10.1016\/j.micpath.2025.107605_bib44","doi-asserted-by":"crossref","unstructured":"Trend of extensively drug\u2010resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3\u2010year period | Letters in Applied Microbiology | Oxford Academic.\u201d Accessed: March. 17, 2025. [Online]. Available: https:\/\/academic.oup.com\/lambio\/article-abstract\/63\/6\/466\/6698851.","DOI":"10.1111\/lam.12669"},{"key":"10.1016\/j.micpath.2025.107605_bib45","doi-asserted-by":"crossref","first-page":"997897","DOI":"10.3389\/fcimb.2022.997897","article-title":"Diversity of resistant determinants, virulence factors, and mobile genetic elements in Acinetobacter baumannii from India: a comprehensive in silico genome analysis","volume":"12","author":"Kumkar","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/mjdrdypu.mjdrdypu_646_22","article-title":"Carbapenem resistant acinetobacter baumannii: current status of problem in a tertiary care hospital, jaipur","volume":"17","author":"Rajni","year":"2024","journal-title":"Med. J. Dr Patil Vidyapeeth"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib47","first-page":"1124","article-title":"Genomic analysis of carbapenem-resistant acinetobacter baumannii isolated from bloodstream infections in South Korea","volume":"13","author":"Jeon","year":"2024","journal-title":"Antibiot. Basel Switz."},{"key":"10.1016\/j.micpath.2025.107605_bib48","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.2147\/IDR.S288865","article-title":"Molecular characterization of carbapenem\/colistin-resistant acinetobacter baumannii clinical isolates from Egypt by whole-genome sequencing","volume":"13","author":"Fam","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2025.107605_bib49","doi-asserted-by":"crossref","first-page":"100952","DOI":"10.1016\/j.genrep.2020.100952","article-title":"Molecular characterization of lpxACD and pmrA\/B two-component regulatory system in the colistin resistance Acinetobacter baumannii clinical isolates","volume":"21","author":"Ghahraman","year":"2020","journal-title":"Gene Rep"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/dku356","article-title":"The spread of carbapenemase-producing bacteria in Africa: a systematic review","volume":"70","author":"Manenzhe","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib51","first-page":"7380740","article-title":"Molecular detection of carbapenemase-encoding genes in multidrug-resistant acinetobacter baumannii clinical isolates in South Africa","volume":"2020","author":"Anane","year":"2020","journal-title":"Internet J. Microbiol."},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271355","article-title":"Acinetobacter baumannii complex, national laboratory-based surveillance in South Africa, 2017 to 2019","volume":"17","author":"Perovic","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib53","first-page":"40","article-title":"Outbreak of multidrug-resistant acinetobacter baumannii in a tertiary health center from northwestern Nigeria","volume":"23","author":"Mohammed","year":"2024","journal-title":"Ann. Afr. Med."},{"key":"10.1016\/j.micpath.2025.107605_bib54","doi-asserted-by":"crossref","first-page":"587398","DOI":"10.3389\/fmicb.2020.587398","article-title":"Prevalence and characterization of carbapenem-hydrolyzing class D \u03b2-lactamase-producing acinetobacter isolates from Ghana","volume":"11","author":"Ayibieke","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib55","doi-asserted-by":"crossref","first-page":"628736","DOI":"10.3389\/fmicb.2021.628736","article-title":"Molecular epidemiology of carbapenem-resistant acinetobacter baumannii from khartoum state, Sudan","volume":"12","author":"Al-Hassan","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijid.2019.11.021","article-title":"Clonal expansion of colistin-resistant Acinetobacter baumannii isolates in Cape Town, South Africa","volume":"91","author":"Snyman","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107605_bib57","doi-asserted-by":"crossref","first-page":"863129","DOI":"10.3389\/fmicb.2022.863129","article-title":"Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa","volume":"13","author":"Lowe","year":"2022","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11050594","article-title":"Whole-genome sequencing of a colistin-resistant acinetobacter baumannii strain isolated at a tertiary health facility in pretoria, South Africa","volume":"11","author":"Nogbou","year":"2022","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resmic.2003.10.003","article-title":"Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals","volume":"155","author":"Van Dessel","year":"2004","journal-title":"Res. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/jac\/dkq407","article-title":"Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy","volume":"66","author":"D'Arezzo","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib61","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.11.20117-en","article-title":"Identification of OXA-23-producing acinetobacter baumannii in Greece, 2010 to 2011","volume":"17","author":"Liakopoulos","year":"2012","journal-title":"Euro Surveill."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eimc.2019.03.008","article-title":"First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain","volume":"38","author":"Fern\u00e1ndez-Cuenca","year":"2020","journal-title":"Enfermedades Infecc. Microbiol. Clin. Engl. Ed"},{"issue":"Jan","key":"10.1016\/j.micpath.2025.107605_bib63","article-title":"Colistin resistant A. Baumannii: genomic and transcriptomic traits acquired under colistin therapy","volume":"9","author":"Cafiso","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib64","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.csbj.2022.12.045","article-title":"Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii","volume":"21","author":"Kabic","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.micpath.2025.107605_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00668","article-title":"Abundance of colistin-resistant, OXA-23- and ArmA-producing acinetobacter baumannii belonging to international clone 2 in Greece","volume":"11","author":"Palmieri","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib67","first-page":"100896","article-title":"Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii ST2 in Oceania: a multicountry cohort study","volume":"40","author":"Baleivanualala","year":"2023","journal-title":"Lancet Reg. Health West. Pac."},{"issue":"1561","key":"10.1016\/j.micpath.2025.107605_bib68","first-page":"76","article-title":"Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand","volume":"135","author":"Roberts","year":"2022","journal-title":"N. Z. Med. J."},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib69","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-0691.2008.02068.x","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia","volume":"14","author":"Le Hello","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib70","first-page":"mgen000530","article-title":"Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care","volume":"7","author":"Roberts","year":"2021","journal-title":"Microb. Genom."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib71","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.00834-10","article-title":"Colistin resistance in acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production","volume":"54","author":"Moffatt","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib72","first-page":"953417","article-title":"Prevalence and genetic characterization of carbapenem- and polymyxin-resistant acinetobacter baumannii isolated from a tertiary hospital in terengganu, Malaysia","volume":"2014","author":"Lean","year":"2014","journal-title":"Int. Sch. Res. Not."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jhm.2477","article-title":"Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: a survey study","volume":"11","author":"Zilberberg","year":"2016","journal-title":"J. Hosp. Med."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib74","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/JCM.00619-11","article-title":"Molecular epidemiology of carbapenem-nonsusceptible acinetobacter baumannii in the United States","volume":"49","author":"Adams-Haduch","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib75","doi-asserted-by":"crossref","unstructured":"A. Iovleva et al., \u201cCarbapenem-resistant acinetobacter baumannii in U.S. Hospitals: diversification of circulating lineages and antimicrobial resistance,\u201d mBio, vol. 13, no. 2, pp. e02759-21, doi: 10.1128\/mbio.02759-21.","DOI":"10.1128\/mbio.02759-21"},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib76","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/mdr.2021.0352","article-title":"Molecular epidemiology of carbapenem-resistant acinetobacter baumannii in the United States, 2013\u20132017","volume":"28","author":"McKay","year":"2022","journal-title":"Microb. Drug Resist. Larchmt. N"},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib77","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/civ048","article-title":"Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance","volume":"60","author":"Qureshi","year":"2015","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.micpath.2025.107605_bib78","doi-asserted-by":"crossref","first-page":"622704","DOI":"10.3389\/fmicb.2021.622704","article-title":"Polymyxin resistance among XDR ST1 carbapenem-resistant acinetobacter baumannii clone expanding in a teaching hospital","volume":"12","author":"Carrasco","year":"2021","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib79","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1469-0691.2005.01227.x","article-title":"Clinical impact and pathogenicity of Acinetobacter","volume":"11","author":"Joly-Guillou","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2025.107605_bib80","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13756-023-01343-8","article-title":"Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon","volume":"12","author":"Itani","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib81","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1086\/508360","article-title":"Colonization or infection with multidrug-resistant acinetobacter baumannii may Be an independent risk factor for increased mortality","volume":"43","author":"Gkrania-Klotsas","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JCM.00766-10","article-title":"Diversity and clinical impact of acinetobacter baumannii colonization and infection at a military medical center","volume":"49","author":"Petersen","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"Mar","key":"10.1016\/j.micpath.2025.107605_bib83","article-title":"Comparative respiratory tract microbiome between carbapenem-resistant acinetobacter baumannii colonization and ventilator associated pneumonia","volume":"13","author":"Xiao","year":"2022","journal-title":"Front. Microbiol."},{"issue":"0","key":"10.1016\/j.micpath.2025.107605_bib84","article-title":"Clinical outcomes and pharmacokinetics\/pharmacodynamics of intravenous polymyxin B treatment for various site carbapenem-resistant gram-negative bacterial infections: a prospective observational multicenter study","volume":"0","author":"Yu","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41598-022-26009-0","article-title":"The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.qco.0000216626.05821.40","article-title":"What is healthcare-associated pneumonia, and how should it be treated?","volume":"19","author":"Craven","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib87","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.00051-05","article-title":"Ventilator-associated pneumonia: diagnosis, treatment, and prevention","volume":"19","author":"Koenig","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib88","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","article-title":"The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: a systematic review and meta-analysis","volume":"79","author":"Mohd Sazlly Lim","year":"2019","journal-title":"J. Infect."},{"key":"10.1016\/j.micpath.2025.107605_bib89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/IDR.S492299","article-title":"Etiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in tertiary-care hospitals in Thailand: a multicenter, retrospective cohort study","volume":"18","author":"Rongrungruang","year":"2025","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib90","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4269\/ajtmh.23-0820","article-title":"Case report: severe community-acquired pneumonia in r\u00e9union island due to acinetobacter baumannii","volume":"111","author":"Rotini","year":"2024","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib91","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1440-1843.2009.01630.x","article-title":"Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia\u2013Pacific","volume":"14","author":"Ong","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.micpath.2025.107605_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12879-019-4733-5","article-title":"Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib93","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3947\/ic.2017.49.4.297","article-title":"A case of community-acquired pneumonia caused by multidrug-resistant acinetobacter baumannii in Korea","volume":"49","author":"Son","year":"2017","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib94","doi-asserted-by":"crossref","unstructured":"I. R. Brigo, L. de R. Yamamoto, and R. J. Molina, \u201cCommunity-acquired Acinetobacter baumannii pneumonia: a rare case in Brazil,\u201d Rev. Soc. Bras. Med. Trop., vol. 55, pp. e0301-e2022, doi: 10.1590\/0037-8682-0301-2022.","DOI":"10.1590\/0037-8682-0301-2022"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/14.1.83","article-title":"Community-acquired acinetobacter pneumonia in the northern territory of Australia","volume":"14","author":"Anstey","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib96","doi-asserted-by":"crossref","first-page":"102456","DOI":"10.1016\/j.jiph.2024.05.044","article-title":"Emergence of novel hypervirulent Acinetobacter baumannii strain and herpes simplex type 1 virus in a case of community-acquired pneumonia in China","volume":"17","author":"Wang","year":"2024","journal-title":"J. Infect. Public Health"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib97","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/AAC.01520-13","article-title":"Epidemiology of bloodstream infections caused by acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes","volume":"57","author":"Chopra","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib98","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/microorganisms11092178","article-title":"Acinetobacter baumannii bloodstream infections: a nationwide study in Israel","volume":"11","author":"Nutman","year":"2023","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib99","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/314040","article-title":"Nosocomial bloodstream infections caused by acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility","volume":"31","author":"Wisplinghoff","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107605_bib100","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.2147\/IDR.S484546","article-title":"Risk factors for development and mortality of bloodstream infections caused by carbapenem-resistant acinetobacter baumannii","volume":"17","author":"Li","year":"2024","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib101","first-page":"285","article-title":"Predictors of thirty-day mortality among patients with blood stream infection with WHO priority pathogens: single centre exploratory study from a referral teaching hospital in central India","volume":"16","author":"Budhiraja","year":"2024","journal-title":"Iran. J. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/sur.2009.022","article-title":"Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease","volume":"11","author":"Guerrero","year":"2010","journal-title":"Surg. Infect."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib103","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1086\/518170","article-title":"An outbreak of multidrug-resistant acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq","volume":"44","author":"Scott","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib104","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BCR.0B013E318031A20F","article-title":"Outcomes of acinetobacter baumannii infection in critically ill burned patients","volume":"28","author":"Trottier","year":"2007","journal-title":"J. Burn Care Res."},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib105","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.burns.2007.03.003","article-title":"Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumannii in a tropical climate","volume":"33","author":"Chim","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.micpath.2025.107605_bib106","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.2147\/IDR.S472025","article-title":"Antimicrobial resistance patterns of pathogens isolated from patients with wound infection at a teaching hospital in Vietnam","volume":"17","author":"An","year":"2024","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib107","first-page":"42","article-title":"Antimicrobial resistance and predisposing factors associated with catheter-associated uti caused by uropathogens exhibiting multidrug-resistant patterns: a 3-year retrospective study at a tertiary hospital in mogadishu, Somalia","volume":"7","author":"Mohamed","year":"2022","journal-title":"Trav. Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajic.2017.08.037","article-title":"Prospective surveillance of device-associated health care\u2013associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India","volume":"46","author":"Kumar","year":"2018","journal-title":"Am. J. Infect. Control"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib109","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41467-019-10706-y","article-title":"Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes","volume":"10","author":"Di Venanzio","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10020127","article-title":"Acinetobacter baumannii: its clinical significance in human and veterinary medicine","volume":"10","author":"Nocera","year":"2021","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-020-0617-7","article-title":"Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection","volume":"27","author":"Nie","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib112","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.tim.2023.06.007","article-title":"The intracellular life of Acinetobacter baumannii","volume":"31","author":"Maure","year":"2023","journal-title":"Trends Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib113","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.str.2016.10.009","article-title":"OmpA: a flexible clamp for bacterial cell wall attachment","volume":"24","author":"Samsudin","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.micpath.2025.107605_bib114","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41522-023-00465-6","article-title":"Csu pili dependent biofilm formation and virulence of Acinetobacter baumannii","volume":"9","author":"Ahmad","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib115","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1099\/mic.0.26541-0","article-title":"Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system","volume":"149","author":"Tomaras","year":"2003","journal-title":"Microbiology"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib116","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/antibiotics12121749","article-title":"Virulence factors and pathogenicity mechanisms of acinetobacter baumannii in respiratory infectious diseases","volume":"12","author":"Yao","year":"2023","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib117","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00258-22","article-title":"InvL, an invasin-like adhesin, is a type II secretion system substrate required for acinetobacter baumannii uropathogenesis","volume":"13","author":"Jackson-Litteken","year":"2022","journal-title":"mBio"},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib118","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.tim.2017.01.005","article-title":"The secrets of Acinetobacter secretion","volume":"25","author":"Weber","year":"2017","journal-title":"Trends Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib119","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2217\/fmb-2020-0032","article-title":"Host\u2013pathogen interactions in acinetobacter baumannii infection: recent advances and future challenges","volume":"15","author":"Chen","year":"2020","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib120","doi-asserted-by":"crossref","unstructured":"F.-J. Li, L. Starrs, and G. Burgio, \u201cTug of war between Acinetobacter baumannii and host immune responses\u201d, Accessed: Feb. 20, 2025. [Online]. Available: https:\/\/dx.doi.org\/10.1093\/femspd\/ftz004.","DOI":"10.1093\/femspd\/ftz004"},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib121","doi-asserted-by":"crossref","first-page":"e00604","DOI":"10.1128\/mSystems.00604-20","article-title":"Acinetobacter baumannii targets human carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) for invasion of pneumocytes","volume":"5","author":"Ambrosi","year":"2020","journal-title":"mSystems"},{"issue":"32","key":"10.1016\/j.micpath.2025.107605_bib122","doi-asserted-by":"crossref","first-page":"26901","DOI":"10.1074\/jbc.M112.344556","article-title":"Platelet-activating factor receptor initiates contact of acinetobacter baumannii expressing phosphorylcholine with host cells","volume":"287","author":"Smani","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib123","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1128\/IAI.73.12.7827-7835.2005","article-title":"\u03b2-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae","volume":"73","author":"Radin","year":"2005","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011173","article-title":"Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH","volume":"19","author":"Distel","year":"2023","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010308","article-title":"Correlative proteomics identify the key roles of stress tolerance strategies in Acinetobacter baumannii in response to polymyxin and human macrophages","volume":"18","author":"Kho","year":"2022","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/dna.2021.0588","article-title":"Acinetobacter baumannii: virulence strategies and host defense mechanisms","volume":"41","author":"Tiku","year":"2022","journal-title":"DNA Cell Biol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib127","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41418-017-0041-z","article-title":"Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection","volume":"25","author":"Li","year":"2018","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/pathogens10040387","article-title":"Acinetobacter baumannii: an ancient commensal with weapons of a pathogen","volume":"10","author":"Sarshar","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2025.107605_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.870101","article-title":"Acinetobacter baumannii secretes a bioactive lipid that triggers inflammatory signaling and cell death","volume":"13","author":"Tiku","year":"2022","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167068","article-title":"Iron-regulated phospholipase C activity contributes to the cytolytic activity and virulence of acinetobacter baumannii","volume":"11","author":"Fiester","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub Moubareck","year":"2020","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/j.micpath.2025.107605_bib132","doi-asserted-by":"crossref","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-Lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib133","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1973947812Y.0000000032","article-title":"Carbapenems","volume":"25","author":"Breilh","year":"2013","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7164\/antibiotics.32.1","article-title":"THIENAMYCIN, a new \u03b2-LACTAM antibiotic I. DISCOVERY, taxonomy, isolation and physical properties","volume":"32","author":"Kahan","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib136","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1469-0691.2008.02101.x","article-title":"New developments in carbapenems","volume":"14","author":"Kattan","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib137","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/1040841X.2011.552880","article-title":"Evolution of \u03b2-lactams resistance in Gram-negative bacteria in Tunisia","volume":"37","author":"Chouchani","year":"2011","journal-title":"Crit. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib138","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkr056","article-title":"Comparative activity of carbapenem testing: the COMPACT study","volume":"66","author":"Nordmann","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib139","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JCM.38.11.4086-4095.2000","article-title":"Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant acinetobacter baumannii","volume":"38","author":"Corbella","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib140","first-page":"282","article-title":"\u201cCarbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync,\u201d Iran","volume":"13","author":"Vahhabi","year":"2021","journal-title":"J. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib141","unstructured":"\u201cbeta-Lactamases in laboratory and clinical resistance | Clin. Microbiol. Rev. Accessed: March. 16, 2025. [Online]. Available: https:\/\/journals.asm.org\/doi\/10.1128\/cmr.8.4.557."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib142","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01676-18","article-title":"OXA-23 is a prevalent mechanism contributing to sulbactam resistance in diverse acinetobacter baumannii clinical strains","volume":"63","author":"Yang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1036","key":"10.1016\/j.micpath.2025.107605_bib143","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of \u03b2-lactamases","volume":"289","year":"1980","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib144","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for beta-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of \u03b2-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib146","doi-asserted-by":"crossref","first-page":"115242","DOI":"10.1016\/j.diagmicrobio.2020.115242","article-title":"A comprehensive and contemporary \u2018snapshot\u2019 of \u03b2-lactamases in carbapenem resistant Acinetobacter baumannii","volume":"99","author":"Hujer","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib147","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/AAC.00762-13","article-title":"Structures of the class D carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam","volume":"57","author":"Kaitany","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib148","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.chembiol.2013.07.015","article-title":"Structural basis for carbapenemase activity of the OXA-23 \u03b2-lactamase from acinetobacter baumannii","volume":"20","author":"Smith","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.micpath.2025.107605_bib149","unstructured":"Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis | Proc. Natl. Acad. Sci. USA. Accessed: July. 10, 2024. [Online]. Available: https:\/\/www.pnas.org\/doi\/abs\/10.1073\/pnas.0607557104."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jac\/dkn553","article-title":"Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase","volume":"63","author":"Lu","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib151","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jac\/dks382","article-title":"Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility","volume":"68","author":"Zander","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib153","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"Pt 3","key":"10.1016\/j.micpath.2025.107605_bib154","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S1399004713033014","article-title":"Structure of the extended-spectrum class C \u03b2-lactamase ADC-1 from Acinetobacter baumannii","volume":"70","author":"Bhattacharya","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkaa390","article-title":"Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder","volume":"76","author":"Johansson","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib156","article-title":"Evolution of a clade of Acinetobacter baumannii global clone 1, lineage 1 via acquisition of carbapenem- and aminoglycoside-resistance genes and dispersion of ISAba1","volume":"5","author":"Hamidian","year":"2019","journal-title":"Microb. Genom."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib157","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib158","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"Jul","key":"10.1016\/j.micpath.2025.107605_bib159","article-title":"Exploration of antibiotic activity of aminoglycosides, in particular ribostamycin alone and in combination with ethylenediaminetetraacetic acid against pathogenic bacteria","volume":"11","author":"Kong","year":"2020","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/archdischild-2015-309069","article-title":"What do I need to know about aminoglycoside antibiotics?","volume":"102","author":"Germovsek","year":"2017","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib161","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1517\/14656566.2013.806486","article-title":"Aminoglycoside therapy in infectious diseases","volume":"14","author":"Poulikakos","year":"2013","journal-title":"Expet Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib162","doi-asserted-by":"crossref","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib163","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijantimicag.2014.12.031","article-title":"Tetracyclines for multidrug-resistant Acinetobacter baumannii infections","volume":"45","author":"Falagas","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib164","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib165","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"issue":"Supplement_2","key":"10.1016\/j.micpath.2025.107605_bib166","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1086\/428051","article-title":"The quinolones: past, present, and future","volume":"41","author":"Andriole","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.micpath.2025.107605_bib167","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2165\/00003495-199500492-00005","article-title":"Classification and structure-activity relationships of fluoroquinolones","volume":"49","author":"Bryskier","year":"1995","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib168","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: mechanism of action, classification, and development of resistance","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv. Ophthalmol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib169","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.micpath.2025.107605_bib170","series-title":"StatPearls, Treasure Island (FL)","article-title":"Quinolones","author":"Yan","year":"2024"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib171","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1038\/s41598-024-53441-1","article-title":"Ciprofloxacin- and levofloxacin-loaded nanoparticles efficiently suppressed fluoroquinolone resistance and biofilm formation in Acinetobacter baumannii","volume":"14","author":"Aboelenin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107605_bib172","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1874285801812010116","article-title":"Molecular study of quinolone resistance determining regions of gyrA gene and parC genes in clinical isolates of acintobacter baumannii resistant to fluoroquinolone","volume":"12","author":"Zaki","year":"2018","journal-title":"Open Microbiol. J."},{"issue":"6","key":"10.1016\/j.micpath.2025.107605_bib173","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/39.6.757","article-title":"Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii","volume":"39","author":"Vila","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib174","doi-asserted-by":"crossref","first-page":"105444","DOI":"10.1016\/j.meegid.2023.105444","article-title":"Insights into the genetic contexts of sulfonamide resistance among early clinical isolates of Acinetobacter baumannii","volume":"112","author":"Bala","year":"2023","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2025.107605_bib175","unstructured":"Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000 - PubMed.\u201d Accessed: Mar. 17, 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/12654674\/."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib176","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","article-title":"Penicillin-binding proteins and \u03b2-lactam resistance","volume":"32","author":"Zapun","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib177","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol"},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib178","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1128\/AAC.00459-11","article-title":"Analysis of genes encoding penicillin-binding proteins in clinical isolates of acinetobacter baumannii","volume":"55","author":"Cay\u00f4","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib179","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1038\/s41467-023-39966-5","article-title":"Molecular basis of \u03b2-lactam antibiotic resistance of ESKAPE bacterium E. faecium Penicillin Binding Protein PBP5","volume":"14","author":"Hunashal","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciu213","article-title":"Colistin and polymyxin B: peas in a pod, or chalk and cheese?","volume":"59","author":"Nation","year":"2014","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib181","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/microorganisms8111716","article-title":"Colistin update on its mechanism of action and resistance, present and future challenges","volume":"8","author":"Andrade","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib182","doi-asserted-by":"crossref","first-page":"20951","DOI":"10.1038\/s41598-022-25226-x","article-title":"The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii","volume":"12","author":"Seleim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107605_bib183","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib184","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/antibiotics10070838","article-title":"Characterisation of colistin -resistant enterobacterales and acinetobacter strains carrying mcr genes from asian aquaculture products","volume":"10","author":"Kalov\u00e1","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107605_bib185","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3389\/fmicb.2019.00953","article-title":"Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in Escherichia coli","volume":"10","author":"Choi","year":"2019","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib186","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fern\u00e1ndez","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2025.107605_bib187","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2012.08.019","article-title":"The OmpA family of proteins: roles in bacterial pathogenesis and immunity","volume":"163","author":"Confer","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib188","doi-asserted-by":"crossref","first-page":"100779","DOI":"10.1016\/j.nmni.2020.100779","article-title":"Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran","volume":"38","author":"Mortazavi","year":"2020","journal-title":"New Microbes New Infect"},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib189","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/jac\/dkr267","article-title":"Structure\u2013function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii","volume":"66","author":"Catel-Ferreira","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib190","doi-asserted-by":"crossref","first-page":"589234","DOI":"10.3389\/fmicb.2020.589234","article-title":"The outer membrane proteins OmpA, CarO, and OprD of acinetobacter baumannii confer a two-pronged defense in facilitating its success as a potent human pathogen","volume":"11","author":"Uppalapati","year":"2020","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib191","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib192","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib193","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/5584_2023_771","article-title":"Different efflux pump systems in acinetobacter baumannii and their role in multidrug resistance","volume":"1370","author":"Sharma","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.micpath.2025.107605_bib194","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/IDR.S228089","article-title":"Acinetobacter baumannii efflux pumps and antibiotic resistance","volume":"13","author":"Abdi","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib195","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.45.12.3375-3380.2001","article-title":"Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in acinetobacter baumannii strain BM4454","volume":"45","author":"Magnet","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib196","article-title":"RND pumps across the genus Acinetobacter: AdeIJK is the universal efflux pump","volume":"9","author":"Darby","year":"2023","journal-title":"Microb. Genom."},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib197","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1128\/AAC.00155-10","article-title":"Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in acinetobacter baumannii","volume":"54","author":"Coyne","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib198","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2478\/v10042-008-0056-x","article-title":"Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics","volume":"46","author":"Wieczorek","year":"2008","journal-title":"Folia Histochem. Cytobiol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib199","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/AAC.48.9.3298-3304.2004","article-title":"Expression of the RND-type efflux pump AdeABC in acinetobacter baumannii is regulated by the AdeRS two-component system","volume":"48","author":"Marchand","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/AAC.00732-07","article-title":"AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in acinetobacter baumannii","volume":"52","author":"Damier-Piolle","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib201","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/AAC.01037-09","article-title":"Screening and quantification of the expression of antibiotic resistance genes in acinetobacter baumannii with a microarray","volume":"54","author":"Coyne","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Supplement_2","key":"10.1016\/j.micpath.2025.107605_bib202","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/cid\/ciad109","article-title":"Global epidemiology and mechanisms of resistance of acinetobacter baumannii-calcoaceticus complex","volume":"76","author":"Castanheira","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib203","article-title":"Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii","volume":"5","author":"Boinett","year":"2019","journal-title":"Microb. Genom."},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/14787210.6.3.269","article-title":"Why are we afraid of Acinetobacter baumannii?","volume":"6","author":"Perez","year":"2008","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib205","first-page":"14","article-title":"Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian tertiary hospital ICU","volume":"8","author":"Nwadike","year":"2014","journal-title":"Afr. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib206","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/antibiotics9040205","article-title":"Acinetobacter baumannii resistance: a real challenge for clinicians","volume":"9","author":"V\u00e1zquez-L\u00f3pez","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107605_bib207","doi-asserted-by":"crossref","unstructured":"J. C. Abdul-Mutakabbir et al., \u201cIn vitro antibacterial activity of cefiderocol against multidrug-resistant acinetobacter baumannii,\u201d Antimicrob. Agents Chemother., vol. 65, no. 9, pp. e02646-20, doi: 10.1128\/AAC.02646-20.","DOI":"10.1128\/AAC.02646-20"},{"issue":"7","key":"10.1016\/j.micpath.2025.107605_bib208","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/biom14070783","article-title":"Third-generation tetracyclines: current knowledge and therapeutic potential","volume":"14","author":"Kounatidis","year":"2024","journal-title":"Biomolecules"},{"issue":"7995","key":"10.1016\/j.micpath.2025.107605_bib209","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","article-title":"A novel antibiotic class targeting the lipopolysaccharide transporter","volume":"625","author":"Zampaloni","year":"2024","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.micpath.2025.107605_bib210","first-page":"310","article-title":"Current concepts in combination antibiotic therapy for critically ill patients","volume":"18","author":"Ahmed","year":"2014","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/03009734.2014.899279","article-title":"Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria","volume":"119","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Upsala J. Med. Sci."},{"key":"10.1016\/j.micpath.2025.107605_bib212","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/IDR.S172137","article-title":"Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis","volume":"11","author":"Jiang","year":"2018","journal-title":"Infect. Drug Resist."},{"issue":"11","key":"10.1016\/j.micpath.2025.107605_bib213","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.3390\/jcm11113239","article-title":"Colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrug-resistant acinetobacter baumannii infection: a meta-analysis","volume":"11","author":"Huang","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micpath.2025.107605_bib214","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jgar.2022.05.011","article-title":"In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance","volume":"30","author":"Findlay","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.micpath.2025.107605_bib215","doi-asserted-by":"crossref","first-page":"15290","DOI":"10.1038\/s41598-019-51711-x","article-title":"Monotherapy versus combination therapy for multidrug-resistant gram-negative infections: systematic review and meta-analysis","volume":"9","author":"Schmid","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib216","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diagmicrobio.2018.01.008","article-title":"In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates","volume":"91","author":"Singkham-in","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib217","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1038\/s41598-022-11464-6","article-title":"In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane\/tazobactam against carbapenem-resistant Acinetobacter baumannii","volume":"12","author":"Ju","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib218","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/antibiotics12010093","article-title":"In vitro synergistic activity of antimicrobial combinations against carbapenem- and colistin-resistant acinetobacter baumannii and Klebsiella pneumoniae","volume":"12","author":"Mantzana","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107605_bib219","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fcimb.2017.00209","article-title":"In vitro evaluation of the colistin-carbapenem combination in clinical isolates of A. Baumannii using the checkerboard, etest, and time-kill curve techniques","volume":"7","author":"Soudeiha","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107605_bib220","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1177\/0300060519879336","article-title":"Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem","volume":"47","author":"Park","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib221","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","article-title":"Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages","volume":"74","author":"Cisek","year":"2017","journal-title":"Curr. Microbiol."},{"issue":"Jan","key":"10.1016\/j.micpath.2025.107605_bib222","article-title":"Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant acinetobacter baumannii in mice","volume":"8","author":"Hua","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib223","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.resmic.2010.03.007","article-title":"Isolation and characterization of \u03d5AB2: a novel bacteriophage of Acinetobacter baumannii","volume":"161","author":"Lin","year":"2010","journal-title":"Res. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib224","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/s41598-022-06582-0","article-title":"Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii","volume":"12","author":"Wintachai","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107605_bib225","article-title":"Characterization and efficacy against carbapenem-resistant Acinetobacter baumannii of a novel Friunavirus phage from sewage","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib226","doi-asserted-by":"crossref","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research progress in multiple fields","volume":"11","author":"Huan","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107605_bib227","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/DDDT.S405579","article-title":"Antimicrobial peptide Cec4 eradicates multidrug-resistant acinetobacter baumannii in vitro and in vivo","volume":"17","author":"Peng","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib228","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1038\/s41598-021-86844-5","article-title":"Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia","volume":"11","author":"Jung","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib229","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3390\/ph16091281","article-title":"An update on the therapeutic potential of antimicrobial peptides against acinetobacter baumannii infections","volume":"16","author":"Rangel","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2025.107605_bib230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jgar.2018.11.007","article-title":"Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from eastern Europe: results from the tigecycline evaluation and surveillance trial (T.E.S.T.), 2011\u20132016","volume":"17","author":"Dowzicky","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib231","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1038\/s41598-020-74401-5","article-title":"The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics","volume":"10","author":"Sancho-Vaello","year":"2020","journal-title":"Sci. Rep."},{"issue":"Oct","key":"10.1016\/j.micpath.2025.107605_bib232","article-title":"Antimicrobial peptide 2K4L disrupts the membrane of multidrug-resistant Acinetobacter baumannii and protects mice against sepsis","volume":"14","author":"Ji","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib233","doi-asserted-by":"crossref","first-page":"15852","DOI":"10.1038\/s41598-022-20236-1","article-title":"Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes","volume":"12","author":"Jariyarattanarach","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micpath.2025.107605_bib234","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14787210.2016.1126508","article-title":"Use of adjuvants in the treatment of Acinetobacter baumannii","volume":"14","author":"Pach\u00f3n-Ib\u00e1\u00f1ez","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib235","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1038\/s41598-024-60627-0","article-title":"Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii","volume":"14","author":"Thadtapong","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.micpath.2025.107605_bib236","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dkac445","article-title":"Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii","volume":"78","author":"Kim","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.107605_bib237","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00892-19","article-title":"Safety, tolerability, pharmacokinetics, and drug interaction potential of SPR741, an intravenous potentiator, after single and multiple ascending doses and when combined with \u03b2-lactam antibiotics in healthy subjects","volume":"63","author":"Eckburg","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107605_bib238","doi-asserted-by":"crossref","first-page":"115329","DOI":"10.1016\/j.ejmech.2023.115329","article-title":"Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii","volume":"253","author":"Marrujo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib239","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s11033-024-09979-4","article-title":"A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles","volume":"51","author":"Teymouri","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2025.107605_bib240","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-024-02373-z","article-title":"Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii","volume":"22","author":"Lan","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107605_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/genes9100477","article-title":"Exploration of survival traits, probiotic determinants, host interactions, and functional evolution of bifidobacterial genomes using comparative genomics","volume":"9","author":"Sharma","year":"2018","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.micpath.2025.107605_bib242","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13030197","article-title":"Types and mechanisms of efflux pump systems and the potential of efflux pump inhibitors in the restoration of antimicrobial susceptibility, with a special reference to acinetobacter baumannii","volume":"13","author":"Zack","year":"2024","journal-title":"Pathogens"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025003304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025003304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:06:54Z","timestamp":1769202414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025003304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":239,"alternative-id":["S0882401025003304"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107605","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acinetobacter baumannii: A comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107605"}}